Abbott Laboratories 

$110.18
3730
+$0.88+0.81% 今天

統計

當日最高
111
當日最低
108.94
52週高點
141.23
52週低點
105.27
成交量
2,849,546
平均成交量
8,055,457
市值
191.59B
本益比
15.53
股息殖利率
2.31%
股息
2.54

即將到來

股息

2.31%股息殖利率
Feb 26
$0.63
Nov 25
$0.59
Aug 25
$0.59
May 25
$0.59
Feb 25
$0.59
10年成長
9.25%
5年成長
6.96%
3年成長
7.3%
1年成長
6.78%

財報

22Apr預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
下一步
1.07
1.21
1.36
1.5
預期EPS
1.153064
實際EPS
不適用

財務

31.95%利潤率
有盈利
2019
2020
2021
2022
2023
2024
83.9B營收
26.8B淨利

分析師評級

$138.55平均目標價
最高預估為 146.00。
來自過去6個月內的 11 則評分。這不是投資建議。
買入
100%
持有
0%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 ABT 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Show more...
執行長
Mr. Robert B. Ford
員工
114000
國家
US
ISIN
US0028241000

上市

0 Comments

分享你的想法

FAQ

Abbott Laboratories 今天的股價是多少?
ABT 目前價格為 $110.18 USD,過去 24 小時上漲了 +0.81%。在圖表上更密切關注 Abbott Laboratories 股價表現。
Abbott Laboratories 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Abbott Laboratories 的股票以代號 ABT 進行交易。
Abbott Laboratories 的股價在上漲嗎?
ABT 股票較上週上漲 +1.56%,本月下跌 -11.05%,過去一年 Abbott Laboratories 下跌 -13.65%。
Abbott Laboratories 的市值是多少?
今天 Abbott Laboratories 的市值為 191.59B
Abbott Laboratories 下一次財報日期是什麼時候?
Abbott Laboratories 將於 April 22, 2026 公布下一次財報。
Abbott Laboratories 上一季度的財報如何?
ABT 上一季度的財報為每股 1.5 USD,預估為 1.5 USD,帶來 +0.29% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Abbott Laboratories 去年的營收是多少?
Abbott Laboratories 去年的營收為 83.9BUSD。
Abbott Laboratories 去年的淨利是多少?
ABT 去年的淨收益為 26.8BUSD。
Abbott Laboratories 會發放股息嗎?
是的,ABT 的股息每 每季 發放一次。每股最新股息為 0.59 USD。截至今日,股息殖利率(FWD)% 為 2.31%。
Abbott Laboratories 有多少名員工?
截至 February 02, 2026,公司共有 114,000 名員工。
Abbott Laboratories 位於哪個產業?
Abbott Laboratories從事於Health Care產業。
Abbott Laboratories 何時完成拆股?
Abbott Laboratories 上次拆股發生於 June 01, 1998,比例為 2:1。
Abbott Laboratories 的總部在哪裡?
Abbott Laboratories 的總部位於 US 的 North Chicago。